Cargando…

Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.

Detalles Bibliográficos
Autores principales:	Sempere, Elena Diago, Matilla, Ana, Rodríguez, Carlos, Perelló, Christie, Minguez, Beatriz, Varela, Maria, Urquijo, Juan José, Ampuero, Javier, Prieto, Janire, Pérez, Laura Márquez, Crespo, Javier, Bermúdez, María, Piedra Cerezal, Ana Maria, Diago, Moises, Antoran, Belén Ruiz, Calleja Panero, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:	POSTER PRESENTATIONS: Saturday 25 June: Liver tumours: Clinical aspects except therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252397/ http://dx.doi.org/10.1016/S0168-8278(22)02112-2

Ejemplares similares

Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine
por: Unver, Suat, et al.
Publicado: (2021)

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients
por: Herrán, Aitor Odriozola, et al.
Publicado: (2022)

TERN-101, a farnesoid X receptor agonist, demonstrated similar safety and efficacy in non-alcoholic steatohepatitis patients with coronavirus disease of 2019 (COVID-19) exposure compared to those with no COVID-19 exposure in phase 2a LIFT study
por: Lawitz, Eric, et al.
Publicado: (2022)

Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients
por: Guarino, Maria, et al.
Publicado: (2022)

P203 Earlier identification of human immunodeficiency virus and hepatitis C virus in high-risk emergency departments
por: Fenton, J., et al.
Publicado: (2009)

Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022)

SARS-CoV-2 infection in liver transplant recipients-a single center case series from Romania
por: Husar-Sburlan, Ioana-Alexandra, et al.
Publicado: (2022)

Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
por: Comandini, Ubaldo Visco, et al.
Publicado: (2022)

SARS-CoV-2 induces pericyte procoagulant response associated with portal vein microthrombosis and intrapulmonary vascular dilations in fatal COVID-19
por: Lasagni, Alberto, et al.
Publicado: (2022)

Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap?
por: Montalbano, Marzia, et al.
Publicado: (2022)

Malignant versus benign vertebral collapse: are new imaging techniques useful?
por: Baur-Melnyk, Andrea
Publicado: (2009)

Tumour ablation: technical aspects
por: Widmann, Gerlig, et al.
Publicado: (2009)

Advanced imaging techniques in brain tumors
por: Law, Meng
Publicado: (2009)

2007 World Health Organization classification of tumours of the central nervous system
por: Thurnher, Majda M.
Publicado: (2009)

Meninges in cancer imaging
por: Mahendru, G., et al.
Publicado: (2009)

The child with bone pain: malignancies and mimickers
por: McCarville, M. Beth
Publicado: (2009)

Pediatric tumors of the spine
por: Huisman, Thierry A.G.M.
Publicado: (2009)

Tumour ablation: current role in the kidney, lung and bone
por: Gillams, Alice
Publicado: (2009)

Assessment of malignant liver tumors in children
por: Roebuck, Derek J.
Publicado: (2009)

Tumor-like lesions of the brain
por: Huisman, Thierry A.G.M.
Publicado: (2009)

Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019)

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
por: Rico, Karen, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022)

The impact of COVID-19 on the duration of the liver transplant process in patients presenting for inpatient liver transplant evaluation
por: Cooper, Katherine, et al.
Publicado: (2022)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Impact of COVID-19 on the liver transplant activity in the US: variation by the region, etiology, and cirrhosis complications
por: Singal, Ashwani, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Long-lasting seropositivity after anti SARS-CoV-2 vaccination in pre liver transplant patients
por: Calleri, Alberto, et al.
Publicado: (2022)

Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients
por: Kounis, Ilias, et al.
Publicado: (2022)

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients
por: Davidov, Yana, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) specific cellular and humoral immunity in Corovavirus Disease-2019 (COVID-19) convalescence after liver transplantation-a prospective six month follow-up
por: Kirchner, Theresa, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Liver transplant patients infection rate with SARS-CoV-2 is lower but depend upon the infection rate in the general population and have a better outcome
por: Cohen-Naftaly, Michal, et al.
Publicado: (2022)

Exposure to the SARS-CoV-2 spike protein in an in vitro model of steatosis enhances hepatocyte oxidative stress: implications for COVID-19 and accelerated disease progression
por: Jacobs, Angus, et al.
Publicado: (2022)

Founding mutations explains hotspots of polycystic kidney disease in Southern Spain
por: García Rabaneda, Carmen, et al.
Publicado: (2020)

Podocyte and tubular involvement in AngioJet-induced kidney injury
por: Esteras, Raquel, et al.
Publicado: (2019)

Radiation nephropathy is associated with a glomerular thrombotic microangiopathy and progression to end-stage kidney disease
por: Bertoni, Isabela, et al.
Publicado: (2023)

The mysterious death of the beer drinking champ: potential role for hyperacute water loading and acute hyponatremia
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2022)

PAX2 variant associated with bilateral kidney agenesis and broad intrafamilial disease variability
por: Rasmussen, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tt05k9oao9ejj43ulcp9jmj1qd